Home › Asthma › Ohio › Cleveland
Asthma clinical trials in Cleveland, OH
5 studies for Asthma are looking for participants at sites in and around Cleveland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
RecruitingPhase 3
- Research Site, Cleveland
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
RecruitingPhase 3
- Research Site, Cleveland
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
RecruitingPhase 3
- GSK Investigational Site, Cleveland
Humidity Asthma Interventions for Low Socioeconomic Status Children
Recruiting
- Case Western Reserve University, Cleveland
- Cleveland Clinic, Cleveland
45th Multicenter Airway Research Collaboration
RecruitingPhase 4
- MetroHealth, Cleveland
About Asthma
Asthma causes one's airways to become sore and swollen. An attack means a person's lungs are getting less air. Learn about two types of treatment.
More about Asthma on MedlinePlus
Asthma trials in other cities
- Miami, FL12 studies
- New York City, NY11 studies
- Boston, MA11 studies
- Dallas, TX10 studies
- Oklahoma City, OK10 studies
- Durham, NC10 studies
- Washington, DC9 studies
- The Bronx, NY9 studies
- Kansas City, KS8 studies
- Houston, TX8 studies
- Pittsburgh, PA7 studies
- Charlotte, NC7 studies
Other studies in Cleveland
- Non-Small Cell Lung Cancer44 studies
- Cancer (all types)37 studies
- Breast Cancer35 studies
- Prostate Cancer34 studies
- Heart Failure33 studies
- Metastatic Cancer30 studies
- Ovarian Cancer28 studies
- Lung Cancer26 studies
- Colorectal Cancer24 studies
- Cardiovascular Disease22 studies
- Endometrial Cancer21 studies
- Acute Myeloid Leukemia20 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.